(Q46824200)

25 December 2017

title

Lamotrigine pharmacokinetic/pharmacodynamic modelling in rats (English)

1 reference

25 December 2017

1 reference

1 reference

1 reference

2

1 reference

25 December 2017

author name string

M M Castel-Branco

series ordinal

1

1 reference

25 December 2017

I V Figueiredo

series ordinal

3

1 reference

25 December 2017

M M Caramona

series ordinal

4

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

Fundamental and Clinical Pharmacology

published in

1 reference

25 December 2017

volume

19

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

669-675

1 reference

25 December 2017

Marketed new antiepileptic drugs: are they better than old-generation agents?

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

Long-term tolerability of lamotrigine: data from a 6-year continuation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

Lamotrigine kidney distribution in male rats following a single intraperitoneal dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

Influence of administration vehicles and drug formulations on the pharmacokinetic profile of lamotrigine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

Variation in threshold and pattern of electroshock-induced seizures in rats depending on site of stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

A pharmacokinetic analysis program (multi) for microcomputer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

Basic concepts in pharmaco-dynamic modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00380.X

10.1111/J.1472-8206.2005.00380.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017